2008

Restarting treatment after an interruption reduces the risk of serious events but CD4 recovery falls short of baseline levels

1 April 2008. Related: Conference reports.

Very low rate of MTCT in women on HAART in UK and Ireland who achieve viral suppression

1 April 2008. Related: Conference reports, Pregnancy.

Predictors of mother to child transmission among women initiating HAART in pregnancy in a South African cohort

1 April 2008. Related: Conference reports, Pregnancy.

Maternal and infant outcomes from the DREAM programme

1 April 2008. Related: Conference reports, Pregnancy.

Nevirapine-resistant HIV present in the latent reservoir following single-dose nevirapine for MTCT prevention

1 April 2008. Related: Conference reports, Pregnancy.

Tenofovir plus FTC reduce NNRTI resistance following single dose nevirapine

1 April 2008. Related: Conference reports, Pregnancy.

Response to treatment after single dose NVP exposure in women

1 April 2008. Related: Conference reports, Pregnancy.

Response to treatment after single dose NVP exposure in infants

1 April 2008. Related: Conference reports, Pregnancy.

Other studies looking at birth outcomes

1 April 2008. Related: Conference reports, Pregnancy.

Infant prophylaxis for postnatal transmission

1 April 2008. Related: Conference reports, Pregnancy.

Antiretroviral drug concentrations in breast milk and breastfeeding infants

1 April 2008. Related: Conference reports, Pregnancy.

Maternal breastfeeding prophylaxis

1 April 2008. Related: Conference reports, Pregnancy.

Risk factors for breastfeeding transmission

1 April 2008. Related: Conference reports, Pregnancy.

UK cohort reports sexual HCV reinfection in at least 5% HIV-positive gay men following sustained response to treatment

1 April 2008. Related: Conference reports, Hepatitis coinfection.

MELD score predictive of pre-transplant mortality in HCV coinfected patients

1 April 2008. Related: Conference reports, Hepatitis coinfection.

Does abacavir decrease SVR rates with HCV treatment?

1 April 2008. Related: Conference reports, Hepatitis coinfection.

No effect of interferon maintenance therapy on fibrosis progression in non-responders

1 April 2008. Related: Conference reports, Hepatitis coinfection.

Stem cell transplant from HLA-matched CCR5-delta 32 deleted donor suppresses viraemia in recipient for 8 months without HAART

1 April 2008. Related: Conference reports, Basic science and immunology.

Risk factors for AIDS-defining and non AIDS-defining cancers

1 April 2008. Related: Conference reports, Cancer and HIV.

New PMTCT guidelines for South Africa (Feb 2008)

1 April 2008. Related: Treatment access.

FDA approve 600mg darunavir tablet

1 April 2008. Related: Antiretrovirals.

US study changes use of abacavir/3TC in naive patients with viral load >100,000 copies based on DSMB recommendation

1 April 2008. Related: Antiretrovirals.

A gutsy talk, and a new paper: report from third workshop on HIV persistence

1 April 2008. Related: Basic science and immunology.

Managing stigma report into gay and bisexual African men with HIV released

1 April 2008. Related: Other news.

Volume 9 Number 3/4 March/April 2008 PDF

1 April 2008. Related: PDFs.

Volume 9 Number 1/2 January/February 2008

28 February 2008. Related: Editorial.

CROI 2008 – 12 key areas of research: non-technical summary of 25 studies and presentations

28 February 2008. Related: Special reports, Conference reports.

Volume 9 Number 1/2 January/February 2008 PDF

1 February 2008. Related: PDFs.

15th Conference on Retroviruses and Opportunistic Infections, 2-6 February 2008, Boston

1 February 2008. Related: Conference reports.

Increased risk of myocardial infarction associated with abacavir and ddI

1 February 2008. Related: Conference reports.

Position statement by the D:A:D steering committee

1 February 2008. Related: Conference reports.

3rd International Workshop on Targeting HIV Entry, 7-9 December 2007, Washington DC

1 February 2008. Related: Conference reports.

CXCR4-using HIV found in 8.5% during early HIV infection

1 February 2008. Related: Conference reports.

Background drugs and low maraviroc levels explain resistance in Motivate studies

1 February 2008. Related: Conference reports, Drug resistance.

38th World Conference on Lung Health of the Union Against TB and Lung Disease, December 2007, Cape Town

1 February 2008. Related: Conference reports.

Treatment outcomes in patients who received rifampicin with nevirapine or efavirenz

1 February 2008. Related: Conference reports, TB coinfection.

Boehringer fails to register tipranavir in Brazil after using Brazilian patients in registrational study

1 February 2008. Related: Antiretrovirals, Treatment access.

Raltegravir approved in Europe and available in the UK

1 February 2008. Related: Antiretrovirals.

Paediatric lopinavir/r receives positive opinion from EMEA

1 February 2008. Related: Antiretrovirals.

Etravirine (TMC-125) approved in the US

1 February 2008. Related: Antiretrovirals.

Changes to atazanavir product label in US

1 February 2008. Related: Antiretrovirals.

US treatment guidelines updated (2008)

1 February 2008. Related: Guidelines.

HIV-positive adults with CD4 >500 cells/mm3 have similar mortality rates as the general population after seven years ARV treatment

1 February 2008. Related: Antiretrovirals.

Dual-class mutations affection RTI and NNRTI may be common in experienced patients

1 February 2008. Related: Drug resistance.

Atazanavir exposure in pregnancy

1 February 2008. Related: Pregnancy.

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-positive pregnant women

1 February 2008. Related: Pregnancy.

Predictors of mortality in untreated HIV-positive children

1 February 2008. Related: Paediatric care.

Pharmacokinetics of lopinavir/ritonavir in infants less than 12 months of age

1 February 2008. Related: Paediatric care.

Comparative study of pegylated interferon formulations in HCV monotherapy

1 February 2008. Related: Hepatitis coinfection.

Probing HIV dependence on host proteins

1 February 2008. Related: Basic science and immunology.

An eye on the benign: pathogenesis lessons from non-pathogenic SIV infections

1 February 2008. Related: Basic science and immunology.

HIV awakens retroviral zombies from cellular slumber

1 February 2008. Related: Basic science and immunology.

Immune activation correlates with CD4 T cell declines in HIV controllers

1 February 2008. Related: Basic science and immunology.

Darunavir/ritonavir interaction with clarithromycin warrants caution

1 February 2008. Related: PK and drug interactions.